127 related articles for article (PubMed ID: 19776089)
1. Topical chemotherapy for ocular surface squamous neoplasia: current status.
Sepulveda R; Pe'er J; Midena E; Seregard S; Dua HS; Singh AD
Br J Ophthalmol; 2010 May; 94(5):532-5. PubMed ID: 19776089
[TBL] [Abstract][Full Text] [Related]
2. Ocular surface squamous neoplasia: a standard of care survey.
Stone DU; Butt AL; Chodosh J
Cornea; 2005 Apr; 24(3):297-300. PubMed ID: 15778602
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant 5-fluorouracil in the treatment of localised ocular surface squamous neoplasia.
Rudkin AK; Muecke JS
Br J Ophthalmol; 2011 Jul; 95(7):947-50. PubMed ID: 21252085
[TBL] [Abstract][Full Text] [Related]
4. Topical medical therapies for ocular surface tumors.
Poothullil AM; Colby KA
Semin Ophthalmol; 2006; 21(3):161-9. PubMed ID: 16912014
[TBL] [Abstract][Full Text] [Related]
5. Topical chemotherapy for ocular surface squamous neoplasia.
Nanji AA; Sayyad FE; Karp CL
Curr Opin Ophthalmol; 2013 Jul; 24(4):336-42. PubMed ID: 23680759
[TBL] [Abstract][Full Text] [Related]
6. Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: Is surgery necessary?
Chaugule SS; Park J; Finger PT
Indian J Ophthalmol; 2018 Jan; 66(1):55-60. PubMed ID: 29283124
[TBL] [Abstract][Full Text] [Related]
7. Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia.
Sturges A; Butt AL; Lai JE; Chodosh J
Ophthalmology; 2008 Aug; 115(8):1297-302, 1302.e1. PubMed ID: 18294690
[TBL] [Abstract][Full Text] [Related]
8. Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy.
Rudkin AK; Dempster L; Muecke JS
Clin Exp Ophthalmol; 2015; 43(1):20-5. PubMed ID: 24995542
[TBL] [Abstract][Full Text] [Related]
9. Intralesional bevacizumab use for invasive ocular surface squamous neoplasia.
Paul S; Stone DU
J Ocul Pharmacol Ther; 2012 Dec; 28(6):647-9. PubMed ID: 22900896
[TBL] [Abstract][Full Text] [Related]
10. Topical mitomycin C chemotherapy in the management of ocular surface neoplasia: a 10-year review of treatment outcomes and complications.
Russell HC; Chadha V; Lockington D; Kemp EG
Br J Ophthalmol; 2010 Oct; 94(10):1316-21. PubMed ID: 20530655
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes after adjunctive topical 5-flurouracil or mitomycin C for the treatment of surgically excised, localized ocular surface squamous neoplasia.
Bahrami B; Greenwell T; Muecke JS
Clin Exp Ophthalmol; 2014; 42(4):317-22. PubMed ID: 23927413
[TBL] [Abstract][Full Text] [Related]
12. Topical 1% 5-fluorouracil in ocular surface squamous neoplasia: a long-term safety study.
Parrozzani R; Lazzarini D; Alemany-Rubio E; Urban F; Midena E
Br J Ophthalmol; 2011 Mar; 95(3):355-9. PubMed ID: 20693564
[TBL] [Abstract][Full Text] [Related]
13. Topical interferon alfa-2b for the treatment of recalcitrant ocular surface squamous neoplasia.
Holcombe DJ; Lee GA
Am J Ophthalmol; 2006 Oct; 142(4):568-71. PubMed ID: 17011846
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant treatment or primary topical monotherapy for ocular surface squamous neoplasia: a systematic review.
Viani GA; Fendi LI
Arq Bras Oftalmol; 2017; 80(2):131-136. PubMed ID: 28591290
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial of topical mitomycin C for ocular surface squamous neoplasia: early resolution.
Hirst LW
Ophthalmology; 2007 May; 114(5):976-82. PubMed ID: 17241666
[TBL] [Abstract][Full Text] [Related]
16. Ocular surface squamous neoplasia after corneal graft.
Ramasubramanian A; Shields CL; Sinha N; Shields JA
Am J Ophthalmol; 2010 Jan; 149(1):62-5. PubMed ID: 19846060
[TBL] [Abstract][Full Text] [Related]
17. Topical mitomycin-C for treatment of partially-excised ocular surface squamous neoplasia.
Rahimi F; Alipour F; Ghazizadeh Hashemi H; Hashemian MN; Mehrdad R
Arch Iran Med; 2009 Jan; 12(1):55-9. PubMed ID: 19111031
[TBL] [Abstract][Full Text] [Related]
18. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
Boehm MD; Huang AJ
Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
[TBL] [Abstract][Full Text] [Related]
19. Topical 1% 5-fluoruracil as a sole treatment of corneoconjunctival ocular surface squamous neoplasia: long-term study.
Parrozzani R; Frizziero L; Trainiti S; Testi I; Miglionico G; Pilotto E; Blandamura S; Fassina A; Midena E
Br J Ophthalmol; 2017 Aug; 101(8):1094-1099. PubMed ID: 27941046
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression as a Possible Risk Factor for Interferon Nonresponse in Ocular Surface Squamous Neoplasia.
Ashkenazy N; Karp CL; Wang G; Acosta CM; Galor A
Cornea; 2017 Apr; 36(4):506-510. PubMed ID: 28129301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]